Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.17
Delayed Data
As of Jan 18
 +0.04 / +3.54%
Today’s Change
1.04
Today|||52-Week Range
2.89
+8.33%
Year-to-Date
Institutional investors purchased a net $50.2 thousand shares of GENE during the quarter ended June 2016, and now own 19.68% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/01/2016HEIGHTS CAPITAL MANAGEMENT, INC.  Bought 488.9 Thousand shares of Genetic Technologies Ltd
12/31/2016CUTLER GROUP LP  Bought 4.3 Thousand shares of Genetic Technologies Ltd
12/31/2016SIMPLEX TRADING LLC  Bought 956.00 shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Heights Capital Management, Inc.9.86%1,600,0001,728,000+488,889+44.00%
Sabby Capital LLC6.59%1,070,3331,155,960-529,667-33.10%
Renaissance Technologies LLC3.00%486,680525,614+83,200+20.62%
KCG Americas LLC0.08%13,61514,704-1,022-6.98%
Citadel Advisors LLC0.07%10,64811,500+10,648--
Cutler Group LP0.03%4,8005,184+4,300+860.00%
KMS Financial Services, Inc.0.02%2,7502,97000.00%
UBS Securities LLC0.01%1,6281,758-8,562-84.02%
Morgan Stanley Smith Barney LLC (...0.01%1,0001,08000.00%
Simplex Trading LLC0.01%9561,032+956--

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change